Загрузка...
AT-01 PHASE I TRIAL OF DOSE ESCALATED RADIOSURGERY PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT/PROGRESSIVE GLIOBLASTOMA
BACKGROUND: Management of recurrent glioblastoma (rGBM) after standard initial therapy remains one of the most difficult challenges in oncology. Prior use of salvage stereotactic radiosurgery (SRS) for rGBM often involved maximum prescription doses defined by RTOG 90-05. We performed a prospective P...
Сохранить в:
Главные авторы: | , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Oxford University Press
2014
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217786/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.1 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|